Thank you #ENETS24 for this award! The Clevers Lab Hubrecht Institute Rare Cancers Genomics UMC Utrecht International The Netherlands Cancer Institute Maastricht UMC+ EMBL Barcelona
Nicolas Alcala Matthieu Foll Lynnette Fernandez-Cuesta Jules Derks, MD, PhD
👀 🧵about our work x.com/TalyaDayton/st… & preview cell.com/cancer-cell/ab… by Stefanie Gerstberger, MD PhD Karuna Ganesh

Another rare cancer Data Note from Matthieu Foll and the IARC Rare Cancers Genomics initiative, this time presenting PDTO data.

Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms doi.org/10.1093/gigasc…

Matthieu Foll presenting a new tool to learn about rare cancers
🔸 “reuse” data from EPIC study
🔸data about risk, exposure and lifestyle factors available
🔸 updated survival available soon
Waiting to make tool publicly available
#ESMOSarcomaAndRareCancers24 ESMO - Eur. Oncology

Great talk of émilie Mathian at #ENETs showing convincing data suggesting that we should stop looking for elusive cut-offs and explore new avenues for the classification of lung neuroendocrine tumors. NET Research Foundation Rare Cancers Genomics

#RareDiseaseDay
At IARC, the Rare Cancers Genomics Team Rare Cancers Genomics leads projects to study rare cancers.
An example is the lungNENomics project, which aims to improve diagnosis & management of lung neuroendocrine tumours.
More📄iarc.who.int/news-events/ra…

📺youtube.com/watch?v=5dLOA7…

It is still time to apply if you are looking for a postdoc on single-cell and spatial omics in cancer! rarecancersgenomics.com/vacancies/

Dr. Nicolas Alcala is a scientist with Indian Republican. This is his first NETRF award: 'Because each NET subtype carries specific DNA alterations and seems to make the immune system react differently, we believe that the interaction between tumor DNA and immune cells (1/3)

So grateful for the continuous support from NET Research Foundation!

We’re delighted that IARC’s Dr Nicolas Alcala Nicolas Alcala is among recipients of the Neuroendocrine Tumor Research Foundation’s @CureNETS newest neuroendocrine tumor (NET) research grants to investigators studying the most promising approaches to understanding & treating NETs!

Our paper on patient-derived tumor #organoids of #neuroendocrine neoplasms was published in the Dec2023 issue of @CancerCell!
The Clevers Lab Hans Clevers Rare Cancers Genomics UMC Utrecht International The Netherlands Cancer Institute Maastricht UMC+ NET Research Foundation
A belated 🧵
HNY everyone!
cell.com/cancer-cell/fu… /1

How to best finish 2023? With the talented Emilie Mathian successfully defending her PhD IARC supervised by Matthieu Foll Lynnette Fernandez-Cuesta and Liming Chen! The next generation of researchers dedicated to NET Research Foundation is ready!

NEN in a dish: A patient-derived organoid biobank illuminates potential novel therapeutic opportunities for neuroendocrine neoplasms dlvr.it/T0BlkS

👩‍🔬Exciting seminars this semester with enthusiastic participation from my #MolecularBiology class of the Master in Molecular and Digital Biology Dept. Biology and Biotechnology @UniPV. A huge thank you to Aaron Jex, Andrea Musacchio, and Lynnette Fernandez-Cuesta for showing the beauty of molecular biology in action!🧬

New Cancer Cell: Rare Cancers Genomics IARC team up with Talya Dayton EMBL Barcelona to create mini-tumors of rare @cancers. A story of #biotechnology 🥼🔬 & #conservation 🐨, where we monitor #tumors like endangered species and witness #evolution in action cell.com/cancer-cell/fu… 🧵

The Clevers Lab and the Rare Cancers Genomics Team (IARC/WHO) developed the first organoid model for neuroendocrine tumors. During the development of this new model, they already discovered a potential new treatment for pulmonary NETs: hubrecht.eu/nets. Talya Dayton Nicolas Alcala

Researchers from IARC and Hubrecht Institute have created “mini-tumours” of a rare cancer that affects neuroendocrine cells. They are a powerful #tool to investigate how cancer develops in these cells, and how it may be managed in the clinic.

👉See more: iarc.who.int/news-events/re…

🦓At the meeting of the Advisory Board of the ENETS, the European #NeuroendocrineTumor Society🦓
@ Frascati, Rome, Italy🇮🇹
Working with friends to help advance the Society, its members, NET research&treatment and most of all:
🦓NET patients!
Hans Hofland Stefano Partelli Aurel Perren

Lucky to have the super talented Alexandra Sexton-Oates in the team! Congrats and well deserved!